Deccan Herald » Edit Page » Detailed Story IN PERSPECTIVE By Gopal Dabade Deccan Herald If patents are granted to a company, the price of the drug would be beyond the reach of the masses. Just a few days back several groups of individuals, known popularly by their acronyms as INP+ and PWN, which stand [...]
No Comments »
Filed under: Article, TRIPS
Times of India, June 19, 2007 The much-awaited appeal proceedings in a cancer drug patent case could not begin on Monday as Swiss major Novartis AG, turning the tables on the government, raised a conflict-of-interest objection to the composition of the two-member bench of the Intellectual Property Appellate Board (IPAB). How can an officer who [...]
No Comments »
Filed under: News, Patent Litigation, TRIPS
Financial Express, June 20, 2007 The Intellectual Property Appellate Board (IPAB), which has been formed to give a verdict on various patent cases across the country, may reject Novartis objection on the presence of S Chandrasekharan, the former patent controller, on IPAB. Novartis had objected to Chandrasekharans presence on the board saying he was responsible [...]
No Comments »
Filed under: Article, News, Patent Litigation, TRIPS
In a rather predictable move, Novartis, the swiss multinational company which holds patent for a many medicines used for treating camcer, leukemia, malaria and many others including the the anti retro-viral AIDS medicine has challenged the contentious Section 3(d) introduced via the 2005 Amendments to India’s Patent Act. This unique section which has been specifically [...]
No Comments »
Filed under: News, Patent Litigation, TRIPS
Novartisboycott tagged on Del.icio.us